AI Models in Prostate Cancer Tackle Treatment Disparities Facing...
In an interview with Peers & Perspectives in Oncology, Rana McKay, MD, explains how an AI model can affect the disparitie [...]
Multimodal AI Informing Treatment Decisions in Advanced Prostate Cancer...
Alicia Morgans interviews Gerhardt Attard about groundbreaking research presented at ESMO 2023, utilizing the STAMPEDE data s [...]
Mind the Gap
While all men are at risk for prostate cancer, there are disproportionate gaps in treatment, research, clinical trials and mo [...]
LUGPA Annual Meeting
ArteraAI will be attending LUGPA Annual Meeting, November 2nd - 4th, 2023, Booth #110, Lake Buena Vista, Florida
Clinical Validation of a Multimodal Artificial Intelligence Prognostic Model...
Artera has developed multimodal AI (MMAI)-enabled predictive and prognostic biomarkers for patients with prostate cancer usin [...]
Dr. Parker and Dr. Attard on the utility of...
In this video, Charles Parker, MD, and Gerhardt Attard, MD, PhD, discuss notable findings from the study “External validation [...]
Using AI to Optimize Therapeutic Choices and QOL in...
In an interview with Peers and Perspectives in Oncology, Tim Showalter, MD, MPH, vice president of clinical development at Ar [...]